Positive predictive values for our AI-based drug response predictions are 80% or higher.
We need about 10 million cancer cells to run the full chemosensitivity panel so we ask that you conduct an aggressive woodpecker style FNA, poking as many nodes as possible and putting the cells into our proprietary media tubes (ensures we receive live cells), then of course we need a whole blood sample (2mL).
Blood clots can prevent our ability to run our tests. Very small clots may not be a problem, but in general, clotted blood is not ideal. That is why we ask that doctors send blood in an EDTA or heparin tube.
We do not recommend using ImpriMed's predictions to rule out treatment options. The company's artificial intelligence is optimized to give high positive predictive value to help you find drugs with the highest likelihood of producing positive clinical outcomes. For the bests results, our predictions should be used in conjunction with expert knowledge from a skilled oncologist.
The more samples ImpriMed processes and the more clinical outcomes we receive from our customers, the more accurately our AI models are able to determine which drugs will work best for your patients. (Click to read more)
Most pet insurance plans that cover cancer care will typically cover ImpriMed’s services. Please check with your insurance representative to see if your plan can cover the services.
